Lower risk for bleeding without increase in ischemic events seen for patients with acute coronary syndrome.
Vimkunya is supplied as an injectable suspension; the vaccine is administered intramuscularly as a single 0.8mL dose.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback